Model comparison
Claude 3 Opus vs Sarvam 30B
Head-to-head evidence from 4 shared benchmark results across 2 categories. Overall scores shown here use the public BenchAlign v5 ranking lane.
Public leaderboard positions: Claude 3 Opus #168 (Supported); Sarvam 30B #169 (Estimated). Intervals and evidence labels describe ranking uncertainty, not a guarantee for a specific workload.
Evidence parity. Claude 3 Opus and Sarvam 30B share 4 comparable benchmark results. 0 of 8 categories are comparable. 1 result is unique to Claude 3 Opus; 7 to Sarvam 30B.
Updated July 23, 2026- Shared results
- 4
- Claude 3 Opus only
- 1
- Sarvam 30B only
- 7
- Comparable categories
- 0 / 8
Benchmark data for Claude 3 Opus and Sarvam 30B is coming soon on BenchLM.
Confidence note. This is a partial-evidence comparison with 4 shared benchmark results across 2 evidence categories; 0 of 8 categories currently have scoreable aggregates for both models. Treat the verdict as directional until coverage is more balanced.
Why this result
BenchLM has partial data for these models, but not enough overlapping benchmark coverage to produce a fair score-level comparison yet.
Claude 3 Opus is priced at $15.00 input / $75.00 output per 1M tokens, versus $0.00 input / $0.00 output per 1M tokens for Sarvam 30B. Claude 3 Opus has the larger context window at 200K, compared with 64K for Sarvam 30B.
Category breakdown
Exact category averages are shown below. Not measured means BenchLM does not have enough sourced public coverage for that model and category.
Operational comparison
Runtime and commercial metrics are compared only when both models have a complete sourced value.
| Metric | Claude 3 Opus | Sarvam 30B | Comparison |
|---|---|---|---|
| Input / output priceUSD per 1M tokens | Claude 3 Opus$15 input / $75 output | Sarvam 30B$0 input / $0 output | Sarvam 30B has the lower combined listed price. |
| Generation speedtokens per second | Claude 3 OpusNot available | Sarvam 30BNot available | A complete speed comparison is not available. |
| First-answer latencyseconds to first token | Claude 3 OpusNot available | Sarvam 30BNot available | A complete latency comparison is not available. |
| Context windowmaximum listed tokens | Claude 3 Opus200K | Sarvam 30B64K | Claude 3 Opus lists the larger context window. |
Benchmark Deep Dive
Agentic1 benchmarks
| Benchmark | Claude 3 Opus | Sarvam 30B | Result |
|---|---|---|---|
| τ²-bench resultsSource | — | 34.5% | Not comparable |
Coding2 benchmarks
Reasoning2 benchmarks
Knowledge6 benchmarks
| Benchmark | Claude 3 Opus | Sarvam 30B | Result |
|---|---|---|---|
| Artificial Analysis Intelligence IndexSource | 11.8% | 6.6% | Claude 3 Opus leads |
| AA-GPQA DiamondSource | 48.9% | 63.3% | Sarvam 30B leads |
| AA-HLESource | 3.1% | 7.0% | Sarvam 30B leads |
| AA-Omniscience IndexSource | — | -72.0% | Not comparable |
| AA-Omniscience AccuracySource | — | 12.7% | Not comparable |
| AA-Omniscience Hallucination RateSource | — | 97.0% | Not comparable |
Inst. Following1 benchmarks
| Benchmark | Claude 3 Opus | Sarvam 30B | Result |
|---|---|---|---|
| AA-IFBenchSource | — | 26.5% | Not comparable |
Frequently Asked Questions (3)
Can I compare Claude 3 Opus and Sarvam 30B on BenchLM yet?
Not fully yet. BenchLM is tracking both models, but the sourced benchmark breakdown for this comparison is still coming soon.
Why does this comparison show “coming soon”?
BenchLM only shows category winners and benchmark-level calls when we have sourced results that can be compared fairly. For these models, the public benchmark coverage is not complete enough yet.
What data is available for Claude 3 Opus and Sarvam 30B today?
Claude 3 Opus: $15.00 input / $75.00 output per 1M tokens Sarvam 30B: $0.00 input / $0.00 output per 1M tokens Both model pages still include creator, context window, reasoning mode, and other metadata while benchmark coverage fills in.
Related Comparisons
Choose a model with this week’s evidence
Join 2,000+ readers for ranking moves, pricing changes, and the claims that still need proof.
One email each week. Unsubscribe anytime.